Skip to main content
NCBI home page
Bulletin of the World Health Organization logoLink to Bulletin of the World Health Organization
. 1985;63(6):1055–1068.

Field evaluation of vaccine efficacy.

W A Orenstein, R H Bernier, T J Dondero, A R Hinman, J S Marks, K J Bart, B Sirotkin
PMCID: PMC2536484  PMID: 3879673

Full text

PDF
1055

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Broome C. V., Preblud S. R., Bruner B., McGowan J. E., Hayes P. S., Harris P. P., Elsea W., Fraser D. W. Epidemiology of pertussis, Atlanta, 1977. J Pediatr. 1981 Mar;98(3):362–367. doi: 10.1016/s0022-3476(81)80696-8. [DOI] [PubMed] [Google Scholar]
  2. Gemert W., Valkenburg H. A., Muller A. S. Machakos project studies. Agents affecting health of mother and child in a rural area of Kenya. II. The diagnosis of measles under field conditions. Trop Geogr Med. 1977 Sep;29(3):303–313. [PubMed] [Google Scholar]
  3. Greaves W. L., Orenstein W. A., Hinman A. R., Nersesian W. S. Clinical efficacy of rubella vaccine. Pediatr Infect Dis. 1983 Jul-Aug;2(4):284–286. doi: 10.1097/00006454-198307000-00005. [DOI] [PubMed] [Google Scholar]
  4. Henderson R. H., Sundaresan T. Cluster sampling to assess immunization coverage: a review of experience with a simplified sampling method. Bull World Health Organ. 1982;60(2):253–260. [PMC free article] [PubMed] [Google Scholar]
  5. Hogue C. J., Gaylor D. W., Schulz K. F. Estimators of relative risk for case-control studies. Am J Epidemiol. 1983 Sep;118(3):396–407. doi: 10.1093/oxfordjournals.aje.a113646. [DOI] [PubMed] [Google Scholar]
  6. Hull H. F., Williams P. J., Oldfield F. Measles mortality and vaccine efficacy in rural West Africa. Lancet. 1983 Apr 30;1(8331):972–975. doi: 10.1016/s0140-6736(83)92091-3. [DOI] [PubMed] [Google Scholar]
  7. Linnemann C. C., Jr Measles vaccine: immunity, reinfection and revaccination. Am J Epidemiol. 1973 Jun;97(6):365–371. doi: 10.1093/oxfordjournals.aje.a121517. [DOI] [PubMed] [Google Scholar]
  8. Marks J. S., Halpin T. J., Orenstein W. A. Measles vaccine efficacy in children previously vaccinated at 12 months of age. Pediatrics. 1978 Dec;62(6):955–960. [PubMed] [Google Scholar]
  9. McCormick J. B., Halsey N., Rosenberg R. Measles vaccine efficacy determined from secondary attack rates during a severe epidemic. J Pediatr. 1977 Jan;90(1):13–16. doi: 10.1016/s0022-3476(77)80756-7. [DOI] [PubMed] [Google Scholar]
  10. McIntyre R. C., Preblud S. R., Polloi A., Korean M. Measles and measles vaccine efficacy in a remote island population. Bull World Health Organ. 1982;60(5):767–775. [PMC free article] [PubMed] [Google Scholar]
  11. Peto R., Pike M. C., Armitage P., Breslow N. E., Cox D. R., Howard S. V., Mantel N., McPherson K., Peto J., Smith P. G. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples. Br J Cancer. 1977 Jan;35(1):1–39. doi: 10.1038/bjc.1977.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. SIMPSON R. E. H. Infectiousness of communicable diseases in the household (measles, chickenpox, and mumps). Lancet. 1952 Sep 20;2(6734):549–554. doi: 10.1016/s0140-6736(52)91357-3. [DOI] [PubMed] [Google Scholar]
  13. Smith P. G., Rodrigues L. C., Fine P. E. Assessment of the protective efficacy of vaccines against common diseases using case-control and cohort studies. Int J Epidemiol. 1984 Mar;13(1):87–93. doi: 10.1093/ije/13.1.87. [DOI] [PubMed] [Google Scholar]
  14. Top F. H. Measles in Detroit, 1935 -I, Factors Influencing the Secondary Attack Rate Among Susceptibles at Risk. Am J Public Health Nations Health. 1938 Aug;28(8):935–943. doi: 10.2105/ajph.28.8.935. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Bulletin of the World Health Organization are provided here courtesy of World Health Organization

RESOURCES